These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion. Majumder V, Saha B, Hajra SK, Biswas SK, Saha K. Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):283-90. PubMed ID: 11221091 [Abstract] [Full Text] [Related]
4. Single lesion paucibacillary leprosy: baseline profile of the Brazilian Multicenter Cohort Study. Martelli CM, Stefani MM, Gomes MK, Rebello PF, Peninni S, Narahashi K, Maroclo AL, Costa MB, Silva SA, Sacchetim SC, Nery JA, Salles AM, Gillis TP, Krahenbuhl JL, Andrade AL. Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):247-57. PubMed ID: 11221086 [Abstract] [Full Text] [Related]
5. A comparative clinico-pathological study of single dose ROM in paucibacillary leprosy patients with 1-3 skin lesions. Deshmukh AR, Dhurat RS, Jerajani HR. Indian J Lepr; 2003 Sep; 75(3):209-17. PubMed ID: 15267190 [Abstract] [Full Text] [Related]
7. Mycobacterium leprae DNA associated with type 1 reactions in single lesion paucibacillary leprosy treated with single dose rifampin, ofloxacin, and minocycline. Sousa AL, Stefani MM, Pereira GA, Costa MB, Rebello PF, Gomes MK, Narahashi K, Gillis TP, Krahenbuhl JL, Martelli CM. Am J Trop Med Hyg; 2007 Nov; 77(5):829-33. PubMed ID: 17984336 [Abstract] [Full Text] [Related]
18. Single dose ROM therapy in Goa. Shukla P, Miranda MS, Prabhudesai R, Rege VL. Indian J Lepr; 2002 Nov; 74(2):169-72. PubMed ID: 12708738 [No Abstract] [Full Text] [Related]